Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood.

Page TH, Turner JJ, Brown AC, Timms EM, Inglis JJ, Brennan FM, Foxwell BM, Ray KP, Feldmann M.

J Immunol. 2010 Sep 15;185(6):3694-701. doi: 10.4049/jimmunol.1000906. Epub 2010 Aug 16.

2.

Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.

Sumariwalla PF, Palmer CD, Pickford LB, Feldmann M, Foxwell BM, Brennan FM.

Rheumatology (Oxford). 2009 Jan;48(1):32-8. doi: 10.1093/rheumatology/ken398. Epub 2008 Nov 16.

PMID:
19015145
3.

In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.

Ounissi-Benkalha H, Pelletier JP, Tardif G, Mineau F, Jolicoeur FC, Ranger P, Martel-Pelletier J.

J Rheumatol. 1996 Jan;23(1):16-23.

PMID:
8838503
4.

Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production.

Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M.

J Leukoc Biol. 2004 Jul;76(1):227-36. Epub 2004 Apr 1.

PMID:
15075356
5.
7.

Nonsteroidal anti-inflammatory drugs increase tumor necrosis factor production in the periphery but not in the central nervous system in mice and rats.

Sacco S, Agnello D, Sottocorno M, Lozza G, Monopoli A, Villa P, Ghezzi P.

J Neurochem. 1998 Nov;71(5):2063-70.

9.

Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.

Schmidt EM, Davies M, Mistry P, Green P, Giddins G, Feldmann M, Stoop AA, Brennan FM.

Arthritis Rheum. 2013 Sep;65(9):2262-73. doi: 10.1002/art.38055.

10.

Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target.

Capellino S, Cosentino M, Wolff C, Schmidt M, Grifka J, Straub RH.

Ann Rheum Dis. 2010 Oct;69(10):1853-60. doi: 10.1136/ard.2009.119701. Epub 2010 May 24.

PMID:
20498218
11.

Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis.

Cutolo M, Sulli A, Ghiorzo P, Pizzorni C, Craviotto C, Villaggio B.

Ann Rheum Dis. 2003 Apr;62(4):297-302.

12.
13.

Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis.

Kitamura T, Kabuyama Y, Kamataki A, Homma MK, Kobayashi H, Aota S, Kikuchi S, Homma Y.

Am J Physiol Cell Physiol. 2008 Jan;294(1):C189-96. Epub 2007 Oct 17.

14.

Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.

Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R.

Arthritis Rheum. 2010 Mar;62(3):683-93. doi: 10.1002/art.27304.

15.

Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.

Hope HR, Anderson GD, Burnette BL, Compton RP, Devraj RV, Hirsch JL, Keith RH, Li X, Mbalaviele G, Messing DM, Saabye MJ, Schindler JF, Selness SR, Stillwell LI, Webb EG, Zhang J, Monahan JB.

J Pharmacol Exp Ther. 2009 Dec;331(3):882-95. doi: 10.1124/jpet.109.158329. Epub 2009 Aug 31.

16.
17.

Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.

González E, de la Cruz C, de Nicoläs R, Egido J, Herrero-Beaumont G.

Agents Actions. 1994 May;41(3-4):171-8.

PMID:
7942325
18.

Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.

Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Tsurumoto T, Kono M, Shindo H, Ida H, Origuchi T, Eguchi K.

J Rheumatol. 2009 Nov;36(11):2397-402. doi: 10.3899/jrheum.090132. Epub 2009 Oct 1.

PMID:
19797510
19.

[Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].

Meyer O.

Bull Acad Natl Med. 2003;187(5):935-54; discussion 954-5. Review. French.

PMID:
14979058
20.

Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.

Smith MD, Slavotinek J, Au V, Weedon H, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ.

Rheumatology (Oxford). 2001 Sep;40(9):965-77.

PMID:
11561106

Supplemental Content

Support Center